|
1
|
Erratum: Global cancer statistics 2018:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 70(313)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mengoli MC, Longo FR, Fraggetta F, Cavazza
A, Dubini A, Alì G, Guddo F, Gilioli E, Bogina G, Nannini N, et al:
The 2015 world health organization classification of lung tumors:
New entities since the 2004 Classification. Pathologica. 110:39–67.
2018.PubMed/NCBI
|
|
3
|
Ruiz-Cordero R and Devine WP: Targeted
therapy and checkpoint immunotherapy in lung cancer. Surg Pathol
Clin. 13:17–33. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gao M, Kong W, Huang Z and Xie Z:
Identification of key genes related to lung squamous cell carcinoma
using bioinformatics analysis. Int J Mol Sci.
21(2994)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhong X, Coukos G and Zhang L: miRNAs in
human cancer. Methods Mol Biol. 822:295–306. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jafri MA, Al-Qahtani MH and Shay JW: Role
of miRNAs in human cancer metastasis: Implications for therapeutic
intervention. Semin Cancer Biol. 44:117–131. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang K, Xu K, Leng X, Han Y and Fang Q:
miRNA-9 inhibits proliferation and migration of lung squamous cell
carcinoma cells by regulating NRSF/EGFR. Technol Cancer Res Treat.
19(1533033820945807)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yang J, Rao S, Cao R, Xiao S, Cui X and Ye
L: miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 -
mediated autophagy. Aging (Albany NY). 13:17462–17472.
2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu F, Mao Q, Zhu S and Qiu J:
MicroRNA-155-5p promotes cell proliferation and invasion in lung
squamous cell carcinoma through negative regulation of fibroblast
growth factor 9 expression. J Thorac Dis. 13:3669–3679.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hu J, Xiang X, Guan W, Lou W, He J, Chen
J, Fu Y and Lou G: MiR-497-5p down-regulates CDCA4 to restrains
lung squamous cell carcinoma progression. J Cardiothorac Surg.
16(330)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shan C, Fei F, Li F, Zhuang B, Zheng Y,
Wan Y and Chen J: miR-448 is a novel prognostic factor of lung
squamous cell carcinoma and regulates cells growth and metastasis
by targeting DCLK1. Biomed Pharmacother. 89:1227–1234.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q,
Wei Q, Li X, Wang J and Zeng H: MicroRNA-494-3p targets CXCR4 to
suppress the proliferation, invasion, and migration of prostate
cancer. Prostate. 74:756–767. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lin H, Huang ZP, Liu J, Qiu Y, Tao YP,
Wang MC, Yao H, Hou KZ, Gu FM and Xu XF: MiR-494-3p promotes
PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma
progression by targeting PTEN. Sci Rep. 8(10461)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li XT, Wang HZ, Wu ZW, Yang TQ, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Huang YL, et al: miR-494-3p
regulates cellular proliferation, invasion, migration, and
apoptosis by PTEN/AKT signaling in human glioblastoma cells. Cell
Mol Neurobiol. 35:679–687. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang Y, Guo L, Li Y, Feng GH, Teng F, Li
W and Zhou Q: MicroRNA-494 promotes cancer progression and targets
adenomatous polyposis coli in colorectal cancer. Mol Cancer.
17(1)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Buccheri G, Ferrigno D and Tamburini M:
Karnofsky and ECOG performance status scoring in lung cancer: A
prospective, longitudinal study of 536 patients from a single
institution. Eur J Cancer. 32A:1135–1141. 1996.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang J, Wang N, Li ZJ, Yang LJ, Jing YG,
Cheng JM and Li J: Identification of key genes and construction of
microRNA-mRNA regulatory networks in non-small cell lung cancer.
Cancer Genet. 228:47–54. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hayashita Y, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and
Takahashi T: A polycistronic microRNA cluster, miR-17-92, is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Res. 65:9628–9632. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu K, Liu S, Zhang W, Jia B, Tan L, Jin Z
and Liu Y: miR-494 promotes cell proliferation, migration and
invasion, and increased sorafenib resistance in hepatocellular
carcinoma by targeting PTEN. Oncol Rep. 34:1003–1010.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu L, Jiang Y, Zhang H, Greenlee AR and
Han Z: Overexpressed miR-494 down-regulates PTEN gene expression in
cells transformed by
anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide. Life Sci.
86:192–198. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang J, Chen H, Liao Y, Chen N, Liu T and
Zhang H and Zhang H: Expression and clinical evidence of miR-494
and PTEN in non-small cell lung cancer. Tumour Biol. 36:6965–6972.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhu L, Wang X, Wang T, Zhu W and Zhou X:
miR4943p promotes the progression of endometrial cancer by
regulating the PTEN/PI3K/AKT pathway. Mol Med Rep. 19:581–588.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang J, Zhu Y, Hu L, Yan F and Chen J:
miR-494 induces EndMT and promotes the development of HCC
(hepatocellular carcinoma) by targeting SIRT3/TGF-β/SMAD signaling
pathway. Sci Rep. 9(7213)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yu J, Wang Z, Kinzler KW, Vogelstein B and
Zhang L: PUMA mediates the apoptotic response to p53 in colorectal
cancer cells. Proc Natl Acad Sci USA. 100:1931–1936.
2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ambros V: MicroRNA pathways in flies and
worms: Growth, death, fat, stress, and timing. Cell. 113:673–676.
2003.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Raponi M, Dossey L, Jatkoe T, Wu X, Chen
G, Fan H and Beer DG: MicroRNA classifiers for predicting prognosis
of squamous cell lung cancer. Cancer Res. 69:5776–5783.
2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Moriya Y, Nohata N, Kinoshita T, Mutallip
M, Okamoto T, Yoshida S, Suzuki M, Yoshino I and Seki N: Tumor
suppressive microRNA-133a regulates novel molecular networks in
lung squamous cell carcinoma. J Hum Genet. 57:38–45.
2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kumamoto T, Seki N, Mataki H, Mizuno K,
Kamikawaji K, Samukawa T, Koshizuka K, Goto Y and Inoue H:
Regulation of TPD52 by antitumor microRNA-218 suppresses cancer
cell migration and invasion in lung squamous cell carcinoma. Int J
Oncol. 49:1870–1880. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cai B and Peng JH: Increased Expression of
miR-494 in serum of patients with prostate cancer and its potential
diagnostic value. Clin Lab. 65:2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kwak SY, Yang JS, Kim BY, Bae IH and Han
YH: Ionizing radiation-inducible miR-494 promotes glioma cell
invasion through EGFR stabilization by targeting p190B rhoGAP.
Biochim Biophys Acta. 1843:508–516. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lim L, Balakrishnan A, Huskey N, Jones KD,
Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, et al:
MicroRNA-494 within an oncogenic microRNA megacluster regulates
G1/S transition in liver tumorigenesis through suppression of
mutated in colorectal cancer. Hepatology. 59:202–215.
2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ambroise G, Portier A, Roders N, Arnoult D
and Vazquez A: Subcellular localization of PUMA regulates its
pro-apoptotic activity in Burkitt's lymphoma B cells. Oncotarget.
6:38181–38194. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yu J and Zhang L: PUMA, a potent killer
with or without p53. Oncogene. 27 (Suppl 1):S71–S83.
2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yang S, Zhu Z, Zhang X, Zhang N and Yao Z:
Idelalisib induces PUMA-dependent apoptosis in colon cancer cells.
Oncotarget. 8:6102–6113. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Funamizu N, Lacy CR, Kamada M, Yanaga K
and Manome Y: MicroRNA-203 induces apoptosis by upregulating Puma
expression in colon and lung cancer cells. Int J Oncol.
47:1981–1988. 2015.PubMed/NCBI View Article : Google Scholar
|
